Spruce Biosciences, Inc.
SPRB
$0.0649
-$0.001-1.52%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -75.86% | -80.41% | -25.64% | 1.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -75.86% | -80.41% | -25.64% | 1.93% |
| Cost of Revenue | 5.04% | 93.31% | -51.43% | -38.37% | -11.91% |
| Gross Profit | -30.33% | -152.77% | 42.88% | 40.88% | 14.70% |
| SG&A Expenses | -15.35% | 12.30% | 6.77% | 18.10% | 25.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.98% | 76.29% | -40.17% | -27.83% | -3.48% |
| Operating Income | -14.72% | -115.64% | 31.12% | 28.17% | 4.29% |
| Income Before Tax | -20.78% | -136.77% | 29.81% | 28.41% | 9.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -20.78% | -136.77% | 29.81% | 28.41% | 9.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.78% | -136.77% | 29.81% | 28.41% | 9.12% |
| EBIT | -14.72% | -115.64% | 31.12% | 28.17% | 4.29% |
| EBITDA | -14.80% | -115.87% | 31.10% | 28.16% | 4.26% |
| EPS Basic | -12.94% | -132.66% | 30.84% | 29.50% | 29.45% |
| Normalized Basic EPS | -12.95% | -132.66% | 30.84% | 29.49% | 29.45% |
| EPS Diluted | -12.94% | -132.66% | 30.84% | 29.50% | 29.45% |
| Normalized Diluted EPS | -12.95% | -132.66% | 30.84% | 29.49% | 29.45% |
| Average Basic Shares Outstanding | 6.93% | 1.74% | 1.45% | 1.52% | 28.83% |
| Average Diluted Shares Outstanding | 6.93% | 1.74% | 1.45% | 1.52% | 28.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |